Statistics

Total Visits

Views
Cabazitaxel in patients with advanced CRPC after Docetaxel-Failure. Results of expanded Program access(EAP) in Spain: Safety and efficacy.26

Select a period of time:

Number of views in the range

Views
Cabazitaxel in patients with advanced CRPC after Docetaxel-Failure. Results of expanded Program access(EAP) in Spain: Safety and efficacy.10

Views

Views
November 20240
December 20240
January 20251
February 20250
March 20254
April 20254
May 20251
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore4
Brazil1
Spain1
United Kingdom1
Georgia1
Hong Kong1
United States1
 

Top cities views

Views
Belo Horizonte1
Billingshurst1
Council Bluffs1
Hong Kong1
Tbilisi1